Treatment according to bone marrow status
| . | Negative BM, n (%) . | Positive BM, n (%) . | All patients, n = (%) . | |||
|---|---|---|---|---|---|---|
| Neoadjuvant chemothepapy | 14 (60.9) | 8 (42.1) | 22 (52.4) | |||
| Surgical treatment (n = 42) | ||||||
| None | 3 (13) | 7 (36.8) | 10 (23.8) | |||
| Segmentectomy | 2 (8.7) | 2 (10.5) | 4 (9.5) | |||
| Modified mastectomy | 10 (43.5) | 9 (47.4) | 19 (45.2) | |||
| Radical mastectomy | 8 (34.8) | 1 (5.3) | 9 (21.4) | |||
| Positive lymph nodes (n = 29) | ||||||
| 0 | 5 (26.3) | 2 (20) | 7 (24.1) | |||
| 1-3 | 8 (42.1) | 3 (30) | 11 (37.9) | |||
| 4-10 | 5 (26.3) | 2 (20) | 7 (24.1) | |||
| >10 | 1 (5.3) | 3 (30) | 4 (13.8) | |||
| Adjuvant chemotherapy (n = 42) | 17 (73.9) | 9 (47.4) | 26 (61.9) | |||
| Palliative chemotherapy (n = 42) | 14 (60.8) | 16 (84.2) | 30 (71.4) | |||
| No. chemotherapy cycles before BM biopsy (n = 42) | ||||||
| 0 | 1 (4.3) | 1 (5.3) | 2 (4.8) | |||
| 4-6 | 11 (47.8) | 6 (31.6) | 17 (40.5) | |||
| 7-10 | 5 (21.7) | 6 (31.6) | 11 (16.2) | |||
| >10 | 6 (26.1) | 6 (31.6) | 12 (28.6) | |||
| Radiation therapy (n = 42) | 20 (87) | 15 (78.9) | 35 (83.3) | |||
| Hormone therapy (n = 42) | 7 (30.4) | 6 (31.6) | 13 (31) | |||
| . | Negative BM, n (%) . | Positive BM, n (%) . | All patients, n = (%) . | |||
|---|---|---|---|---|---|---|
| Neoadjuvant chemothepapy | 14 (60.9) | 8 (42.1) | 22 (52.4) | |||
| Surgical treatment (n = 42) | ||||||
| None | 3 (13) | 7 (36.8) | 10 (23.8) | |||
| Segmentectomy | 2 (8.7) | 2 (10.5) | 4 (9.5) | |||
| Modified mastectomy | 10 (43.5) | 9 (47.4) | 19 (45.2) | |||
| Radical mastectomy | 8 (34.8) | 1 (5.3) | 9 (21.4) | |||
| Positive lymph nodes (n = 29) | ||||||
| 0 | 5 (26.3) | 2 (20) | 7 (24.1) | |||
| 1-3 | 8 (42.1) | 3 (30) | 11 (37.9) | |||
| 4-10 | 5 (26.3) | 2 (20) | 7 (24.1) | |||
| >10 | 1 (5.3) | 3 (30) | 4 (13.8) | |||
| Adjuvant chemotherapy (n = 42) | 17 (73.9) | 9 (47.4) | 26 (61.9) | |||
| Palliative chemotherapy (n = 42) | 14 (60.8) | 16 (84.2) | 30 (71.4) | |||
| No. chemotherapy cycles before BM biopsy (n = 42) | ||||||
| 0 | 1 (4.3) | 1 (5.3) | 2 (4.8) | |||
| 4-6 | 11 (47.8) | 6 (31.6) | 17 (40.5) | |||
| 7-10 | 5 (21.7) | 6 (31.6) | 11 (16.2) | |||
| >10 | 6 (26.1) | 6 (31.6) | 12 (28.6) | |||
| Radiation therapy (n = 42) | 20 (87) | 15 (78.9) | 35 (83.3) | |||
| Hormone therapy (n = 42) | 7 (30.4) | 6 (31.6) | 13 (31) | |||